Annual CFI
-$124.00 K
-$57.00 K-85.07%
December 31, 2023
Summary
- As of February 7, 2025, MBRX annual cash flow from investing activities is -$124.00 thousand, with the most recent change of -$57.00 thousand (-85.07%) on December 31, 2023.
- During the last 3 years, MBRX annual CFI has risen by +$250.00 thousand (+66.84%).
- MBRX annual CFI is now -552.63% below its all-time high of -$19.00 thousand, reached on December 31, 2021.
Performance
MBRX Cash From Investing Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly CFI
$0.00
+$13.00 K+100.00%
September 30, 2024
Summary
- As of February 7, 2025, MBRX quarterly cash flow from investing activities is $0.00, with the most recent change of +$13.00 thousand (+100.00%) on September 30, 2024.
- MBRX quarterly CFI is now -100.00% below its all-time high of $30.00 thousand, reached on June 30, 2016.
Performance
MBRX Quarterly CFI Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
TTM CFI
-$94.00 K
+$28.00 K+22.95%
September 30, 2024
Summary
- As of February 7, 2025, MBRX TTM cash flow from investing activities is -$94.00 thousand, with the most recent change of +$28.00 thousand (+22.95%) on September 30, 2024.
Performance
MBRX TTM CFI Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Cash From Investing Formula
CFI = Cash Inflows from Investments − Cash Outflows for Investments
MBRX Cash From Investing Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | -85.1% | - | - |
| 3 y3 years | +66.8% | +100.0% | -526.7% |
| 5 y5 years | +70.3% | +100.0% | -526.7% |
MBRX Cash From Investing Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3-year | -552.6% | at low | at high | +100.0% | -526.7% | +24.2% |
| 5 y | 5-year | -552.6% | +66.8% | at high | +100.0% | -571.4% | +74.9% |
| alltime | all time | -552.6% | +70.3% | -100.0% | +100.0% | <-9999.0% | +78.8% |
Moleculin Biotech Cash From Investing History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sep 2024 | - | $0.00(-100.0%) | -$94.00 K(-23.0%) |
| Jun 2024 | - | -$13.00 K(-84.0%) | -$122.00 K(-1.6%) |
| Dec 2023 | -$124.00 K(+85.1%) | -$81.00 K(+189.3%) | -$124.00 K(+188.4%) |
| Sep 2023 | - | -$28.00 K(+86.7%) | -$43.00 K(+186.7%) |
| Jun 2023 | - | -$15.00 K(<-9900.0%) | -$15.00 K(-77.6%) |
| Dec 2022 | -$67.00 K(+252.6%) | $0.00(0.0%) | -$67.00 K(-22.1%) |
| Sep 2022 | - | $0.00(-100.0%) | -$86.00 K(0.0%) |
| Jun 2022 | - | -$61.00 K(+916.7%) | -$86.00 K(+244.0%) |
| Mar 2022 | - | -$6000.00(-68.4%) | -$25.00 K(+31.6%) |
| Dec 2021 | -$19.00 K(-94.9%) | -$19.00 K(<-9900.0%) | -$19.00 K(+35.7%) |
| Sep 2021 | - | $0.00(0.0%) | -$14.00 K(-96.0%) |
| Jun 2021 | - | $0.00(0.0%) | -$354.00 K(-4.8%) |
| Mar 2021 | - | $0.00(-100.0%) | -$372.00 K(-0.5%) |
| Dec 2020 | -$374.00 K | -$14.00 K(-95.9%) | -$374.00 K(+1.4%) |
| Sep 2020 | - | -$340.00 K(+1788.9%) | -$369.00 K(+897.3%) |
| Jun 2020 | - | -$18.00 K(+800.0%) | -$37.00 K(-2.6%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Mar 2020 | - | -$2000.00(-77.8%) | -$38.00 K(-25.5%) |
| Dec 2019 | -$51.00 K(-87.8%) | -$9000.00(+12.5%) | -$51.00 K(-67.3%) |
| Sep 2019 | - | -$8000.00(-57.9%) | -$156.00 K(-64.8%) |
| Jun 2019 | - | -$19.00 K(+26.7%) | -$443.00 K(+4.5%) |
| Mar 2019 | - | -$15.00 K(-86.8%) | -$424.00 K(+1.7%) |
| Dec 2018 | -$417.00 K(+1389.3%) | -$114.00 K(-61.4%) | -$417.00 K(+30.7%) |
| Sep 2018 | - | -$295.00 K(<-9900.0%) | -$319.00 K(+896.9%) |
| Jun 2018 | - | $0.00(-100.0%) | -$32.00 K(-11.1%) |
| Mar 2018 | - | -$8000.00(-50.0%) | -$36.00 K(+28.6%) |
| Dec 2017 | -$28.00 K(-76.9%) | -$16.00 K(+100.0%) | -$28.00 K(+21.7%) |
| Sep 2017 | - | -$8000.00(+100.0%) | -$23.00 K(-81.6%) |
| Jun 2017 | - | -$4000.00(<-9900.0%) | -$125.00 K(+37.4%) |
| Mar 2017 | - | $0.00(-100.0%) | -$91.00 K(-24.8%) |
| Dec 2016 | -$121.00 K | -$11.00 K(-90.0%) | -$121.00 K(+10.0%) |
| Sep 2016 | - | -$110.00 K(-466.7%) | -$110.00 K(<-9900.0%) |
| Jun 2016 | - | $30.00 K(-200.0%) | $0.00(-100.0%) |
| Mar 2016 | - | -$30.00 K | -$30.00 K |
FAQ
- What is Moleculin Biotech annual cash flow from investing activities?
- What is the all time high annual CFI for Moleculin Biotech?
- What is Moleculin Biotech annual CFI year-on-year change?
- What is Moleculin Biotech quarterly cash flow from investing activities?
- What is the all time high quarterly CFI for Moleculin Biotech?
- What is Moleculin Biotech TTM cash flow from investing activities?
- What is the all time high TTM CFI for Moleculin Biotech?
What is Moleculin Biotech annual cash flow from investing activities?
The current annual CFI of MBRX is -$124.00 K
What is the all time high annual CFI for Moleculin Biotech?
Moleculin Biotech all-time high annual cash flow from investing activities is -$19.00 K
What is Moleculin Biotech annual CFI year-on-year change?
Over the past year, MBRX annual cash flow from investing activities has changed by -$57.00 K (-85.07%)
What is Moleculin Biotech quarterly cash flow from investing activities?
The current quarterly CFI of MBRX is $0.00
What is the all time high quarterly CFI for Moleculin Biotech?
Moleculin Biotech all-time high quarterly cash flow from investing activities is $30.00 K
What is Moleculin Biotech TTM cash flow from investing activities?
The current TTM CFI of MBRX is -$94.00 K
What is the all time high TTM CFI for Moleculin Biotech?
Moleculin Biotech all-time high TTM cash flow from investing activities is $0.00